Overview
Sabine Hoja practices practicing medicine in Regensburg, Germany.
Her clinical expertise encompasses Glioblastoma, Astrocytoma, Oligodendroglioma, and Glioma.
She is actively involved in clinical research, co-authoring 12 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Sabine Hoja
Is Sabine Hoja a top-rated expert for Glioblastoma?
MediFind is an objective health platform that identifies experts based on real-world data. Sabine Hoja is classified as an Experienced expert for Glioblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Sabine Hoja participate in research or clinical trials?
Yes. Sabine Hoja has published 12 articles and abstracts on conditions like Glioblastoma. You can view a list of Sabine Hoja's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AstrocytomaMs. Hoja isExperienced. Learn about Astrocytoma.
- GlioblastomaMs. Hoja isExperienced. Learn about Glioblastoma.
- GliomaMs. Hoja isExperienced. Learn about Glioma.
- Gliomatosis CerebriMs. Hoja isExperienced. Learn about Gliomatosis Cerebri.
- OligodendrogliomaMs. Hoja isExperienced. Learn about Oligodendroglioma.